Glaukos Corp

Glaukos Corp Stock

109.89P/E
€12.85BMarket capitalisation
-US$2.95Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Corp is registered in the following country: United States of America (Exchange: USNYSE).

Key metrics

Key metrics and master data for the Glaukos Corp stock.

Market capitalisation
€12.85B
P/E
109.89
P/B
19.60
P/S
19.31
P/CF
290.48
Issued shares 59M Units

Return

Here you can see the performance of the Glaukos Corp stock.

PeriodPerfor­mance
1 Week-1.82 %
1 Month+46.94 %
3 Months+35.85 %
6 Months+4.44 %
1 Year+15.34 %
YTD-3.09 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Glaukos Corp share.

DateRatio
No data available.

Which ETF contains the Glaukos Corp stock?

The Glaukos Corp stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Glaukos Corp has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Glaukos Corp stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.